EOM Pharmaceuticals Holdings, Inc.
IMUC · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $92,848 | $95,147 | $28,318 | $26,619 |
| - Cash | $613 | $551 | $0 | $933 |
| + Debt | $3,467 | $3,049 | $0 | $2,776 |
| Enterprise Value | $95,702 | $97,645 | $28,318 | $28,461 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$315 | -$709 | -$515 | -$754 |
| % Margin | – | – | – | – |
| Net Income | -$465 | -$763 | -$634 | -$785 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.007 | -0.006 | -0.007 |
| % Growth | 38.8% | -19.6% | 18.8% | – |
| Operating Cash Flow | -$688 | $0 | – | -$1 |
| Capital Expenditures | $0 | $0 | – | $0 |
| Free Cash Flow | -$688 | $0 | – | -$1 |